New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 24, 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has sold 105,326 shares of the company’s stock. This transaction is valued at an impressive $111,503,592.
Recent Updates on LLY stock
In the past 24 hours, Eli Lilly & Co. has announced updates on several ongoing clinical studies, which could potentially influence its stock performance. These studies include a Phase 2 trial for brenipatide aimed at reducing smoking relapse, a Phase 3 trial for baricitinib to preserve beta-cell function in type 1 diabetes, and another Phase 3 trial to delay the onset of type 1 diabetes in at-risk individuals. Additionally, a Phase 4 study is evaluating the long-term safety of pirtobrutinib in chronic lymphocytic leukemia, and a Phase 3 trial is assessing the efficacy of Vepugratinib in combination with other therapies for advanced urothelial carcinoma. These studies highlight Eli Lilly’s efforts to expand its portfolio in smoking cessation, diabetes management, and oncology. The potential success of these trials could enhance investor sentiment and position Eli Lilly favorably against competitors, impacting market dynamics in these sectors.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s strong financial performance and positive earnings call sentiment are the most significant factors driving the score. The company’s robust revenue growth, market share gains, and strategic pipeline advancements are key strengths. However, high leverage, declining cash flow metrics, and a premium valuation present potential risks.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: 38.29%
Average Trading Volume: 3,809,608
Technical Sentiment Signal: Buy
Current Market Cap: $1001.8B